---All---
  • ---All---
  • Accession
  • Catalog #

AFG3L2 Antibody (N-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP13219a 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP13219a-ev20 Ev20 size 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AFG3L2 Antibody (N-term) - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9Y4W6
Other AccessionQ8JZQ2, Q2KJI7, NP_006787.2
ReactivityHuman
PredictedBovine, Mouse
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW88584 Da

AFG3L2 Antibody (N-term) - Additional info

Gene ID 10939
Other Names
AFG3L2; AFG3-like protein 2; Paraplegin-like protein
Target/Specificity
This AFG3L2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-80 amino acids from the N-terminal region of human AFG3L2.
Dilution
WB~~1:100~500
IHC~~1:10~50
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AFG3L2 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.

AFG3L2 Antibody (N-term) - Protein Information

Name AFG3L2
Function
ATP-dependent protease which is essential for axonal development (By similarity)
Cellular Location
Mitochondrion membrane; Multi-pass membrane protein
Tissue Location
Ubiquitous. Highly expressed in the cerebellar Purkinje cells

AFG3L2 Antibody (N-term) - Related products

AP13219a: AFG3L2 Antibody (N-term)

AFG3L2 Antibody (N-term) - Application data

  • AFG3L2 Antibody (N-term) (Cat. #AP13219a) western blot analysis in MDA-MB453,MCF-7,Jurkat cell line lysates (35ug/lane).This demonstrates the AFG3L2 antibody detected the AFG3L2 protein (arrow).

  • AFG3L2 Antibody (N-term) (Cat. #AP13219a)immunohistochemistry analysis in formalin fixed and paraffin embedded human cerebellum tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of AFG3L2 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.

AFG3L2 Antibody (N-term) - Research Areas

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a protein localized in mitochondria and closely related to paraplegin. The paraplegin gene is responsible for an autosomal recessive form of hereditary spastic paraplegia. This gene is a candidate gene for other hereditary spastic paraplegias or neurodegenerative disorders.

REFERENCES

Edener, U., et al. Eur. J. Hum. Genet. 18(8):965-968(2010) Di Bella, D., et al. Nat. Genet. 42(4):313-321(2010) Augustin, S., et al. Mol. Cell 35(5):574-585(2009) Mariotti, C., et al. Cerebellum 7(2):184-188(2008) Cagnoli, C., et al. Brain 129 (PT 1), 235-242 (2006) :